IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma by Chao Wang, Timothy W. McKeithan, Qiang Gong, Weiwei.

Slides:



Advertisements
Similar presentations
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma by Anamarija M. Perry, Teresa.
Advertisements

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma by Chao Wang, Timothy W. McKeithan, Qiang Gong, Weiwei.
Volume 3, Issue 4, Pages (April 2013)
DNA Methylation Regulates Gene Expression in Intracranial Aneurysms
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states by Thu-Hang Pham, Christopher.
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation  Martin Lauss, Rizwan Haq, Helena Cirenajwis,
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
Volume 20, Issue 13, Pages (September 2017)
Volume 3, Issue 4, Pages (April 2013)
by Christopher J. Ott, Nadja Kopp, Liat Bird, Ronald M
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway by María J. Bueno, Marta Gómez de Cedrón, Gonzalo Gómez-López, Ignacio Pérez de.
Volume 2, Issue 4, Pages (April 2008)
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma by Michela Boi, Andrea Rinaldi, Ivo Kwee, Paola Bonetti, Maria Todaro, Fabrizio.
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features by Maria E. Figueroa, Bas J.
The transcriptional program of terminal granulocytic differentiation
Expression profiling of snoRNAs in normal hematopoiesis and AML
Mutant IDH1 Promotes Glioma Formation In Vivo
Volume 11, Issue 2, Pages (August 2012)
Roger B. Deal, Steven Henikoff  Developmental Cell 
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Volume 29, Issue 1, Pages (April 2014)
Volume 9, Issue 3, Pages (September 2017)
Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia by Floriana Manodoro, Jacek Marzec, Tracy.
Volume 3, Issue 2, Pages (February 2003)
by Laura J. Norton, Alister P. W
Volume 15, Issue 5, Pages (November 2014)
Ying-Ying Yu, Ph. D. , Cui-Xiang Sun, Ph. D. , Yin-Kun Liu, Ph. D
Alice C.L. Len, Shimona Starling, Maitreyi Shivkumar, Clare Jolly 
Volume 44, Issue 1, Pages (October 2011)
Volume 17, Issue 2, Pages (October 2016)
CHK1 downregulation upon ERG overexpression.
Reversing the TERT promoter mutation to WT reverses the active chromatin marks and alters long-range chromatin interactions. Reversing the TERT promoter.
Volume 6, Issue 1, Pages (January 2016)
Mapping Global Histone Acetylation Patterns to Gene Expression
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas by Dong Fang, Haiyun Gan, Jeong-Heon Lee, Jing Han, Zhiquan Wang, Scott M. Riester,
Mira Jeong, Margaret A. Goodell  Experimental Hematology 
Volume 10, Issue 6, Pages (June 2018)
Volume 23, Issue 1, Pages 9-22 (January 2013)
Volume 126, Issue 6, Pages (September 2006)
Volume 7, Issue 9, Pages (September 2014)
Volume 24, Issue 8, Pages (August 2018)
Genome-wide promoter methylation of hairy cell leukemia
Myeloma cell–derived Runx2 promotes myeloma progression in bone
Signatures of the Immune Response
Volume 22, Issue 3, Pages (January 2018)
Volume 10, Issue 10, Pages (October 2017)
Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS by Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Kyohei Yamada,
Volume 16, Issue 2, Pages (July 2016)
Volume 132, Issue 6, Pages (March 2008)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Core promoter methylation in mediators of adipogenesis.
Volume 7, Issue 2, Pages (August 2010)
Significant differences in translational efficiencies of DNA damage repair pathway genes between patient clusters. Significant differences in translational.
Differential binding of H3K36me3 in G34-mutant KNS42 cells drives pediatric GBM expression signatures. Differential binding of H3K36me3 in G34-mutant KNS42.
AZA treatment induces a distinct gene-expression pattern in stromal cells. AZA treatment induces a distinct gene-expression pattern in stromal cells. (A-C)
Volume 10, Issue 3, Pages (March 2017)
Volume 9, Issue 4, Pages (October 2017)
Maria S. Robles, Sean J. Humphrey, Matthias Mann  Cell Metabolism 
Volume 17, Issue 3, Pages (October 2016)
Volume 42, Issue 1, Pages (April 2011)
JAK2V617F leads to increased 5-hmC and genome-wide loss of cytosine methylation in primary patient samples. JAK2V617F leads to increased 5-hmC and genome-wide.
Volume 26, Issue 9, Pages (September 2018)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
CREBBP loss-of-function results in gene expression repression signature. CREBBP loss-of-function results in gene expression repression signature. A–D,
Mutational load and mutations in the interferon signaling pathway among patients with advanced melanoma with or without response to anti–PD-1 blockade.
Mutant TERT promoter displays active histone marks and distinct long-range interactions: A, cell lines that were used in the study with their origin and.
Genome-wide DNA hypomethylation associated with DNMT3A mutation in murine and human FLT3ITD AML. Human: A–C, volcano plot (A) representation of mean methylation.
Presentation transcript:

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma by Chao Wang, Timothy W. McKeithan, Qiang Gong, Weiwei Zhang, Alyssa Bouska, Andreas Rosenwald, Randy D. Gascoyne, Xiwei Wu, Jinhui Wang, Zahid Muhammad, Bei Jiang, Joseph Rohr, Andrew Cannon, Christian Steidl, Kai Fu, Yuping Li, Stacy Hung, Dennis D. Weisenburger, Timothy C. Greiner, Lynette Smith, German Ott, Eleanor G. Rogan, Louis M. Staudt, Julie Vose, Javeed Iqbal, and Wing C. Chan Blood Volume 126(15):1741-1752 October 8, 2015 ©2015 by American Society of Hematology

Mutational profiles of IDH2, TET2, DNMT3A, and RHOA in patients with PTCLs. (A) Co-occurrence of IDH2R172, TET2, DNMT3, and RHOA mutations in patients with AITL (n = 39), subgroups of PTCL-NOS (n = 41), and ALK(−) ALCL (n = 12). Mutational profiles of IDH2, TET2, DNMT3A, and RHOA in patients with PTCLs. (A) Co-occurrence of IDH2R172, TET2, DNMT3, and RHOA mutations in patients with AITL (n = 39), subgroups of PTCL-NOS (n = 41), and ALK(−) ALCL (n = 12). White color indicates wild-type cases. Gray color indicates cases with variant allele frequency (VAF) of ≥3% but <10%. Black color indicates cases with VAF of ≥10%. (B) Mutations occur in functional domains of the TET2 and DNMT3A proteins. Missense mutations, nonsense mutations, and insertion/deletions are indicated. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

IDH2R172 mutations define a unique subgroup of AITL with distinct gene expression. IDH2R172 mutations define a unique subgroup of AITL with distinct gene expression. (A) Dendrogram of unsupervised hierarchical clustering of 37 AITL cases with mutational status of IDH2R172, TET2, and DNMT3A. The branches indicate Pearson's correlation among the samples. Fisher's exact test was performed to determine the significance of the tendency of neighboring cases on the dendrogram to have identical mutation status. (B) Supervised heat map of samples across 1035 genes differentially expressed among IDH2/TET2 double-mutant (n = 12), TET2 single-mutant (n = 18), and wild-type (n = 6) AITL (univariate permutation test, P < .01). The profile on the left shows gene expression in primary CD4+ T cells treated with IL-12 for 0, 2, 8, 24, and 48 hours. Each column represents a case. Green and red color scale indicates row z-score. Selected differentially expressed genes are listed at the right side of the profile. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

Functional annotation of genes differentially expressed between IDH2/TET2 double-mutant AITL and TET2 single-mutant AITL. (A) Selected top IPA canonical pathways differing between IDH2/TET2 double-mutant AITL and TET2 single-mutant AITL. (B) IPA upstream an... Functional annotation of genes differentially expressed between IDH2/TET2 double-mutant AITL and TET2 single-mutant AITL. (A) Selected top IPA canonical pathways differing between IDH2/TET2 double-mutant AITL and TET2 single-mutant AITL. (B) IPA upstream analysis to predicted activation state of annotated proteins. “Vegf” and “Interferon alpha” are groups of proteins instead of single molecules. Activation z-score >3 was considered significant. (C) Apoptosis pathway identified by GSEA analysis significantly altered in IDH2/TET2 double-mutant AITL compared with TET2 single-mutant AITL. The normalized enrichment score, P value, and false discovery rate value are indicated. (D) Correlations between (1) the differences in GEP between each individual AITL case and the median tumor value with (2) the changes in GEP induced in normal CD4+ T-cells by IL-12 (48 hours). (E) Comparison of the number of “TFH-up genes” and “TFH-down genes” (see text) in AITL. Data are shown as mean ± standard error of the mean (SEM). P value was calculated using the 2-tailed Student t test. *P < .05, **P < .01, ***P < .001, and ****P < .0001. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

IDH2R172 mutations are associated with DNA hypermethylation in AITL and T cells. IDH2R172 mutations are associated with DNA hypermethylation in AITL and T cells. (A-B) Simultaneous detection of 5mC and 5hmC in transduced Jurkat cells by the LC-MS/MS method. (C-D) Simultaneous detection of 5mC and 5hmC in transduced human CD4+ T cells by the LC-MS/MS method. (E) LC-MS/MS showing alteration of intracellular 2-HG in corresponding groups (n = 4 each). (F) RRBS showing alterations of methylation level among normal tissues (n = 7, 3 tonsils and 4 CD4+ T-cell samples), IDH2 wild-type AITL (n = 8) and IDH2R172 mutant AITL (n = 10) in different genomic regions. Promoters are ±1-kb regions relative to transcription start site. Gene bodies are regions of transcribed sequences excluding promoter regions. Intergenic regions are the sequences other than promoters and gene bodies. (G) RRBS showing alterations of methylation level in CpG island (CGI), CpG island shore (CGS), and non–CGI-CGS regions. (H) Number of hypermethylated genes in IDH2 wild-type AITL (n = 8) and IDH2R172 mutant AITL (n = 10) compared with normal tissues. Red indicates genes only hypermethylated in IDH2R172-mutant AITL. Green indicates genes only hypermethylated in IDH2 wild-type AITL. Blue indicates genes hypermethylated in both IDH2R172 mutant and IDH2 wild-type AITL. Genes with expression data were divided into deciles based on the mean gene expression level of 5 normal CD4+ T-cell samples (10 = highest). Data are shown as mean ± SEM. P value was calculated using the 2-tailed Student t test. *P < .05, **P < .01, ***P < .001, and ****P < .0001. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

Genes with aberrant expression associated with aberrant methylation in AITL. RRBS methylation analysis (left) and gene expression analysis (right) are shown for 46 hypermethylated and 9 hypomethylated genes between 18 AITL and 7 normal samples. Genes with aberrant expression associated with aberrant methylation in AITL. RRBS methylation analysis (left) and gene expression analysis (right) are shown for 46 hypermethylated and 9 hypomethylated genes between 18 AITL and 7 normal samples. Gene selection criteria include promoters of the selected genes must be significantly hyper- or hypomethylated compared with normal tissue (3 tonsils and 4 CD4+ T-cell samples; P ≤ .05); selected genes must be normally expressed in primary CD4+ T cells; and there must be strong correlation between promoter methylation and gene expression among the samples (R < −0.4). Except for 1 case (indicated with *), all cases with RRBS data have corresponding gene expression data. Mutational statuses of IDH2R172, TET2, and DNMT3A are listed at the top. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

Poised genes tend to be downregulated and hypermethylated in IDH2R172 mutant AITL. (A) GSEA analysis of genes differentially expressed between TET2-single mutant and IDH2/TET2-double mutant groups shows the enrichment of H3K27me3-associated genes. Poised genes tend to be downregulated and hypermethylated in IDH2R172 mutant AITL. (A) GSEA analysis of genes differentially expressed between TET2-single mutant and IDH2/TET2-double mutant groups shows the enrichment of H3K27me3-associated genes. (B) Poised genes expressed in CD4+ T cells are downregulated in AITL with IDH2R172 mutations. (C) Comparison of the DNA methylation patterns between poised genes and nonpoised genes in AITL, analyzing autosomal genes in the top half of mean gene expression in the 4 normal T-cell control samples. The poised genes are significantly more likely to be hypermethylated than nonpoised genes (P = 1.3 × 10−17, Fisher’s exact test). Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology

IDH2R172 mutant alters histone lysine trimethylation in Jurkat T cells and AITL. (A) Western blots showing ectopic expression of wild-type IDH2 and IDH2R172 in whole cell lysates of transduced Jurkat cells. IDH2R172 mutant alters histone lysine trimethylation in Jurkat T cells and AITL. (A) Western blots showing ectopic expression of wild-type IDH2 and IDH2R172 in whole cell lysates of transduced Jurkat cells. LC-MS/MS showing alteration of intracellular 2-HG in corresponding groups (n = 4 each, data are shown as mean ± SEM, ***P < .001 by 2-tailed Student t test). (B) Western blots showing changes in trimethylation of various histone lysine residues in transduced Jurkat cells. Histone proteins were extracted and assessed for levels of histone lysine methylation. Total H3 was used as loading control. Blots shown are representative of ≥3 replicates. (C) Representative immunohistochemistry of AITL tissue microarrays with antibody against H3K27me3 (n = 3 in each group). Original magnification, ×40. (D) Image quantification using Image Scope (details in “Materials and methods”). Error bar indicates SEM of 3 independent samples in each group. Chao Wang et al. Blood 2015;126:1741-1752 ©2015 by American Society of Hematology